Despite shrinking by kr68m in the past week, Integrum shareholders are still up 610 percent over 5 years - Simply Wall St
INTEG-B Stock | SEK 17.50 0.30 1.69% |
About 62% of Integrum's investor base is looking to short. The analysis of current outlook of investing in Integrum AB Series suggests that many traders are alarmed regarding Integrum's prospects. The current market sentiment, together with Integrum's historical and current headlines, can help investors time the market. In addition, many technical investors use Integrum AB Series stock news signals to limit their universe of possible portfolio assets.
Integrum |
Despite shrinking by kr68m in the past week, Integrum shareholders are still up 610 percent over 5 years Simply Wall St
Read at news.google.com
Integrum Fundamental Analysis
We analyze Integrum's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integrum using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integrum based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Integrum is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Integrum AB Series Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Integrum stock to make a market-neutral strategy. Peer analysis of Integrum could also be used in its relative valuation, which is a method of valuing Integrum by comparing valuation metrics with similar companies.
Peers
Integrum Related Equities
BIOVIC-B | Biovica International | 12.99 | ||||
CRAD-B | C Rad | 0.32 | ||||
SUS | Surgical Science | 0.34 | ||||
CANTA | Cantargia | 0.55 | ||||
BONEX | Bonesupport Holding | 3.49 |
Complementary Tools for Integrum Stock analysis
When running Integrum's price analysis, check to measure Integrum's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrum is operating at the current time. Most of Integrum's value examination focuses on studying past and present price action to predict the probability of Integrum's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrum's price. Additionally, you may evaluate how the addition of Integrum to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies |